Todd Dickinson is a founding scientist of Illumina. During his 12-year tenure, he helped establish the product development processes and led several of the earliest project teams. Todd has directed programs in optical chemical detection, the design and development of the early array formats used in Illumina’s industry-leading BeadArray® microarray product lines, and several major strategic programs aimed at developing future-generation sequencing platforms. While at Illumina, Todd also held several sales and marketing management roles. As Director of Product Marketing at Illumina, his teams carried out more than 60 product launches in a two-year period, and achieved triple-digit growths across several product lines.
In 2011, he joined BioNano Genomics, an early-stage genomics technology company in San Diego, to help commercialize a novel nanochannel array platform. During his tenure at BioNano, Todd served as Vice President of Product Development, and subsequently as Vice President of Global Commercial Operations, and led the company’s worldwide launch of its flagship product offering, the Irys™ system. He is an inventor on more than ten patents and patent applications.
He holds undergraduate degrees in chemistry and theology from St. Olaf College, and a PhD in Analytical Chemistry from Tufts University.
Ramesh Ramakrishnan brings to Dovetail more than 25 years experience in biotech and clinical research, and in commercialization of genomic solutions. Prior to joining Dovetail, Dr. Ramakrishnan was Executive Vice President of Research and Development at Fluidigm Corp. He holds a PhD in Zoology from Georgetown University and the University of Poona, India, which he earned through the Fulbright Scholarship Program. Prior to his tenure at Fluidigm, Dr. Ramakrishnan worked at Nanosphere and Motorola Life Sciences in assay and array development.
Veronica Mankinen brings a track record of over 20 years of success in a variety of commercial roles of increasing responsibility for companies such as Fluidigm, BioNano Genomics, Agilent and Applied Biosystems/Life Technologies. She has built and led sales, support and marketing organizations in the genomics industry focused in research and applied applications. Through a focus on delivering the right tools to the right customers to enable their success she delivered triple-digit growth in the Cytogenetics business while at Agilent and in the Food and Animal Pathogen Screening business at Applied Biosystems. She holds a Bachelor’s in Molecular Biology from the University of California, San Diego.
Brandon Rice is one of the original founding members of Dovetail. Brandon did graduate work in bioinformatics in the lab of Richard ‘Ed’ Green at UCSC, where Dovetail’s core technologies were conceived. He performed the early development work on the Chicago method in the lab before joining Dovetail in 2013. Brandon guided Dovetail through the early days of business establishment, intellectual property development, and foundational technology research and development. Now overseeing operations, Brandon is responsible for driving Dovetail’s development programs as well as the deployment of its services and products to market.
Prior to his graduate work, Brandon worked in bioinformatic analysis and software development at the National Center for Genome Resources (NCGR) in Santa Fe, New Mexico. There he developed and maintained extensive bioinformatics software pipelines and studied metabolic and hereditary susceptibility to severe outcomes in sepsis. He studied biology at the University of New Mexico where his focus was evolutionary psychology and genetics.
Nicholas Putnam has worked on computational genome assembly problems during both the transition from clone-based to whole genome shotgun (WGS) sequencing in the early 2000s, and the transition from Sanger to massively parallel sequencing in the last seven years. He served as a genome center group leader and as an academic principal investigator.
In the early 2000s, in collaboration with Jarrod Chapman and Dan Rokhsar, he developed JAZZ, the first whole genome shotgun assembler outside of Celera. JAZZ enabled the D.O.E. Joint Genome Institute to transition from clone-based sequencing of the human genome to a series of diverse plant, animal, and fungal WGS genome sequencing projects. Nik took a variety of roles in these projects, including JGI Group Leader for Genome Assembly. He was Assistant Professor of Ecology and Evolutionary Biology at Rice University from 2008-2013, where he led a research group focused on comparative genomics of chromosome-scale genome organization.
Mathew Easterday serves as Dovetail’s General Counsel. Prior to joining Dovetail Matt was a patent attorney with WSGR in Palo Alto where he worked on IP strategy for dozens of early stage biotech companies.
Matt graduated magna cum laude from University of Minnesota law school and has a Ph.D. from UCLA.